Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser
Susan
S
University of Nebraska College of Law, USA.
D001291:Attitude of Health Personnel; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007880:Legislation, Drug; D016365:Liability, Legal; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*; D010818:Practice Patterns, Physicians'; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations